Telegram
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиNeuroBo Pharmaceuticals Мультипликаторы 2011-2024 | NRBO
Мультипликаторы по годам NeuroBo Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-1.7 | -0.0 | -0.1 | -2.8 | -2.1 | -0.6 | -3.2 | -4.1 | - | - | - | - | - |
P/S |
- | - | - | - | - | - | - | - | - | - | - | - | - |
EPS |
-2.5 | -43.4 | -19.8 | -1.8 | -4.1 | -1.7 | -3.2 | -2.6 | -4.5 | -0.2 | - | - | - |
EV (Enterprise Value) |
4.4 млн | -21.4 млн | -13.4 млн | 77.8 млн | 32.8 млн | 6.63 млн | 103 млн | 40.3 млн | 13.3 млн | 562 тыс. | - | - | - |
EBITDA per Share |
-3.13 | -61 | -19.8 | -1.81 | -3.86 | -41.3 | -80 | -63.2 | - | - | - | - | - |
EV/EBITDA |
-0.6 | -2.5 | -1.5 | -0.2 | -3.0 | -2.5 | - | - | - | - | - | ||
PEG |
-0.01 | -0.0 | -0.0 | -0.05 | -0.02 | -0.01 | 0.12 | -0.32 | - | - | - | - | - |
P/B |
1.2 | 0.0 | 0.1 | 11.7 | 3.6 | 1.8 | 27.0 | 2.9 | - | - | - | - | - |
P/CF |
-1.9 | -0.0 | -0.1 | -7.8 | -6.1 | -0.6 | -4.0 | -5.5 | - | - | - | - | - |
ROE % |
-74.74 | -64.22 | -104.71 | -412.02 | -173.38 | -304.05 | -847.88 | -70.70 | - | - | - | - | - |
ROA % |
-54.74 | -41.65 | -90.98 | -270.59 | -147.30 | -120.02 | -175.71 | -58.92 | - | - | - | - | - |
ROCE % |
-95.21 | -90.24 | -104.80 | -408.58 | -162.89 | -293.31 | -262.33 | -71.23 | - | - | - | - | - |
Current Ratio |
3.7 | 2.8 | 7.6 | 2.9 | 6.8 | 1.7 | 3.0 | 6.0 | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально NeuroBo Pharmaceuticals
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.09 | -0.02 | -0.06 | - | -3.5 | -3.72 | -3.24 | - | -4.66 | -0.18 | -0.15 | - | -0.19 | -0.15 | -0.3 | - | -0.7 | -0.37 | -0.48 | -0.26 | -0.43 | -0.47 | -0.58 | -0.63 | -0.82 | -0.99 | -0.79 | 0.78 | -0.56 | -0.42 | -0.65 | -1.14 | -0.87 | -0.6 | -2.27 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -0.06 | - | -3.47 | -3.6 | -3.22 | - | -4.61 | -0.18 | -0.15 | - | -0.19 | -0.15 | -0.3 | - | -0.7 | -0.37 | -0.47 | -0.64 | -0.41 | -0.46 | -0.57 | -0.62 | -0.8 | -0.99 | -0.79 | -0.78 | -0.49 | -0.51 | -0.64 | -0.67 | -0.87 | -0.55 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-85.75 | -120.46 | -154.94 | -113.92 | -170.43 | -174.51 | -178.48 | -123.15 | -165.55 | -151.44 | -143.17 | -141.16 | -170.62 | -157.68 | -140.05 | -64.97 | -37.45 | -86.19 | -156.63 | -229.51 | -27241.02 | -27382.85 | -27563.43 | -27660.71 | -711.67 | -510.45 | -250.71 | -70.70 | -14.97 | 24.58 | 44.33 | 91.43 | 107.59 | 86.84 | 36.91 | 36.91 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-66.43 | -93.17 | -123.42 | -95.31 | -138.16 | -139.82 | -143.64 | -102.90 | -130.75 | -115.74 | -100.90 | -92.71 | -117.73 | -114.92 | -106.32 | -55.20 | -150.90 | -156.74 | -177.51 | -197.16 | -136.93 | -151.66 | -172.98 | -175.71 | -169.38 | -139.45 | -89.85 | -58.92 | -87.02 | -128.57 | -158.83 | -150.33 | -93.10 | -35.88 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-97.73 | -131.94 | -153.28 | -112.82 | -169.37 | -173.66 | -178.64 | -123.30 | -165.78 | -151.71 | -143.49 | -141.62 | -171.27 | -158.45 | -140.59 | -64.94 | -40.10 | -86.42 | -155.11 | -226.04 | -26518.89 | -26659.59 | -26842.35 | -26941.86 | -708.90 | -508.72 | -250.82 | -71.23 | -15.91 | 19.69 | 41.61 | 52.40 | 32.12 | 13.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
5.4 | 7.3 | 2.9 | 2.9 | 4.7 | 8.1 | 8.8 | 7.6 | 4.1 | 8.6 | 14.0 | 2.9 | 2.9 | 2.9 | 2.9 | 6.7 | 6.7 | 6.7 | 6.7 | 10.6 | 1.6 | 1.6 | 1.6 | 1.3 | 1.3 | 1.3 | 1.3 | 6.0 | 6.0 | 6.0 | 6.0 | 0.5 | 0.5 | 0.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD